Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

China flag China · Delayed Price · Currency is CNY
58.65
-0.07 (-0.12%)
Jul 31, 2025, 1:44 PM CST
-0.12%
Market Cap74.29B
Revenue (ttm)1.89B
Net Income (ttm)-72.25M
Shares Out1.27B
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividend0.32 (0.54%)
Ex-Dividend DateJun 3, 2024
Volume3,447,965
Average Volume4,470,901
Open59.39
Previous Close58.72
Day's Range58.60 - 59.56
52-Week Range57.60 - 89.89
Beta1.57
RSI39.63
Earnings DateAug 28, 2025

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. The company was founded in 1991 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 3,790
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603392
Full Company Profile

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.

Financial Statements

News

There is no news available yet.